Related Experiment Video
Updated: May 8, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Centrimag right ventricular support after tricuspid valvectomy for endocarditis
Maya Guglin1, Charles Glover, Cristiano Faber
1Department of Cardiology, University of South Florida, Tampa, Florida; Tampa General Hospital, Tampa, Florida 33602, USA.
Recurrent endocarditis of bioprosthetic tricuspid valves is difficult to treat. A temporary right ventricular assist device successfully supported a patient until a new valve could be implanted.
Area of Science:
- Cardiology
- Cardiac Surgery
- Biomedical Engineering
Background:
- Recurrent endocarditis poses significant challenges, particularly with bioprosthetic tricuspid valves.
- Complete valvectomy may be necessary in severe cases, necessitating alternative hemodynamic support strategies.
Observation:
- A patient presented with recurrent endocarditis of a bioprosthetic tricuspid valve requiring intervention.
- The case involved the use of a Thoratec Centrimag Blood Pump for temporary hemodynamic support.
Findings:
- The Thoratec Centrimag Blood Pump provided effective temporary hemodynamic support to the right ventricle.
- This support facilitated the safe implantation of a new tricuspid bioprosthesis.
Implications:
- Temporary mechanical circulatory support can be a viable strategy in managing complex tricuspid valve endocarditis.
- This approach may improve outcomes by stabilizing patients for definitive surgical procedures.
Related Concept Videos
Endocarditis III: Medical Management
Cardiomyopathy V: Interprofessional Care
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Endocarditis IV: Nursing Management
Cardiomyopathy II: Dilated Cardiomyopathy
